DalsnaFinance › Analyst accuracy › Needham › LBRX target
Needham initiates LB Pharmaceuticals stock with buy rating
Investing.com - Needham initiated coverage on LB Pharmaceuticals Inc (NASDAQ:LBRX) with a buy rating and set a price target of $68.00.
A fact about what Needham published, as reported by Investing.com, not a recommendation from Dalsna Finance; Needham is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.